We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$9.38B
Cap. Flow %
6.92%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Energy 8.49%
2 Technology 6.67%
3 Healthcare 6.67%
4 Financials 6.58%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRX icon
9576
PUT
TRX Gold Corp
TRX
$255M
$4K ﹤0.01%
2,000
-3,600
-64% -$8.19K
TTSH
9577
PUT
DELISTED
Tile Shop Holdings
TTSH
$4K ﹤0.01%
400
-1,000
-71% -$11.2K
BSIN
9578
CALL
Big Sky Industrial
BSIN
$67M
$4K ﹤0.01%
20
+12
+150% +$2.85K
VCEL icon
9579
Vericel Corp
VCEL
$2.3B
$4K ﹤0.01%
1,373
+1,366
+19,514% +$4.52K
VHC icon
9580
PUT
VirnetX Holding Corp
VHC
$52.3M
$4K ﹤0.01%
30
-240
-89% -$64.3K
VXRT
9581
DELISTED
Vaxart
VXRT
$4K ﹤0.01%
+155
New +$4.45K
WSR
9582
DELISTED
Whitestone REIT
WSR
$4K ﹤0.01%
+313
New +$4.67K
WTW icon
9583
CALL
Willis Towers Watson
WTW
$27.9B
$4K ﹤0.01%
38
FFNW
9584
DELISTED
First Financial Northwest, Inc
FFNW
$4K ﹤0.01%
+433
New +$4.64K
SEEL
9585
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
CMLS
9586
CALL
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$4K ﹤0.01%
+125
New +$4.95K
NBSE
9587
PUT
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$4K ﹤0.01%
1
-106
-99% -$351K
PACW
9588
CALL
DELISTED
PacWest Bancorp
PACW
$4K ﹤0.01%
100
-300
-75% -$12.6K
AEY
9589
DELISTED
ADDvantage Technologies Group
AEY
$4K ﹤0.01%
167
-155
-48% -$3.78K
QUOT
9590
PUT
DELISTED
Quotient Technology Inc
QUOT
$4K ﹤0.01%
+300
New +$5.3K
SPPI
9591
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$4K ﹤0.01%
500
-500
-50% -$3.91K
SRNE
9592
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$4K ﹤0.01%
996
-55
-5% -$295
VIVO
9593
PUT
DELISTED
Meridian Bioscience Inc
VIVO
$4K ﹤0.01%
200
-400
-67% -$7.86K
STAB
9594
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$4K ﹤0.01%
491
+351
+251% +$3.22K
AATC
9595
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
$4K ﹤0.01%
1,182
-36
-3% -$128
RBCN
9596
CALL
DELISTED
Rubicon Technology, Inc.
RBCN
$4K ﹤0.01%
100
-50
-33% -$3.42K
HNGR
9597
PUT
DELISTED
Hanger Inc.
HNGR
$4K ﹤0.01%
+200
New +$5.11K
MBII
9598
DELISTED
Marrone Bio Innovations, Inc.
MBII
$4K ﹤0.01%
1,400
+368
+36% +$2.46K
PBIP
9599
DELISTED
Prudential Bancorp, Inc.
PBIP
$4K ﹤0.01%
+301
New +$3.56K
HMHC
9600
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$4K ﹤0.01%
200
-295
-60% -$5.51K

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.